SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
驽马
Lv5
1090 积分
2021-12-04 加入
最近求助
最近应助
互助留言
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
6个月前
已完结
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected
7个月前
已完结
Integrating liquid biopsies into the management of cancer
7个月前
已完结
Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer
8个月前
已完结
HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer
8个月前
已关闭
HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer
8个月前
已完结
Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis
9个月前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
10个月前
已完结
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
11个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
1年前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了,么么哒
6个月前
感谢,点赞,速度真快,帮大忙了,么么哒
7个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
已找到【积分已退回】
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
9个月前
感谢,点赞,速度真快,帮大忙了,么么哒
10个月前
感谢,点赞,速度真快,帮大忙了,么么哒
11个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1年前
感谢,点赞,速度真快,帮大忙了,么么哒
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论